Total Payments
$6,158
2024 Payments
$407.93
Companies
35
Transactions
397
Medicare Patients
1,387
Medicare Billing
$257,685
Payment Breakdown by Category
Food & Beverage$6,150 (99.9%)
Education$8.08 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,150 | 394 | 99.9% |
| Education | $8.08 | 3 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Sunovion Pharmaceuticals Inc. | $1,136 | 91 | $0 (2020) |
| Otsuka America Pharmaceutical, Inc. | $1,091 | 63 | $0 (2023) |
| Allergan, Inc. | $433.22 | 37 | $0 (2020) |
| Lundbeck LLC | $418.59 | 24 | $0 (2024) |
| Shire North American Group Inc | $365.68 | 25 | $0 (2019) |
| Neos Therapeutics, LP | $267.97 | 12 | $0 (2020) |
| Neurocrine Biosciences, Inc. | $212.69 | 14 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $198.07 | 14 | $0 (2022) |
| Teva Pharmaceuticals USA, Inc. | $179.32 | 10 | $0 (2021) |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $171.95 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $407.93 | 15 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) ($171.95) |
| 2023 | $531.06 | 18 | ITI, Inc. ($159.88) |
| 2022 | $77.26 | 5 | Janssen Pharmaceuticals, Inc ($19.96) |
| 2021 | $162.42 | 9 | Teva Pharmaceuticals USA, Inc. ($40.36) |
| 2020 | $317.82 | 22 | Sunovion Pharmaceuticals Inc. ($127.40) |
| 2019 | $1,455 | 103 | Sunovion Pharmaceuticals Inc. ($371.73) |
| 2018 | $1,558 | 107 | Otsuka America Pharmaceutical, Inc. ($428.23) |
| 2017 | $1,649 | 118 | Otsuka America Pharmaceutical, Inc. ($362.28) |
All Payment Transactions
397 individual payment records from CMS Open Payments — Page 1 of 16
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | Almatica Pharma LLC | LOREEV XR (Drug) | Food and Beverage | In-kind items and services | $13.34 | General |
| Category: ANTI-ANXIETY | ||||||
| 12/04/2024 | IRONSHORE PHARMACEUTICALS INC. | JORNAY PM (Drug) | Food and Beverage | Cash or cash equivalent | $23.40 | General |
| Category: CENTRAL NERVOUS SYSTEM STIMULANT | ||||||
| 12/04/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | In-kind items and services | $14.10 | General |
| Category: SCHIZOPHRENIA | ||||||
| 11/12/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $28.91 | General |
| Category: PSYCHIATRY | ||||||
| 10/22/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $25.31 | General |
| Category: PSYCHIATRY | ||||||
| 09/10/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $18.05 | General |
| Category: PSYCHIATRY | ||||||
| 09/05/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $7.45 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 07/23/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: PSYCHIATRY | ||||||
| 07/09/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | In-kind items and services | $13.31 | General |
| Category: SCHIZOPHRENIA | ||||||
| 05/28/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $26.96 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 05/14/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $19.58 | General |
| Category: PSYCHIATRY | ||||||
| 04/09/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $24.16 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 02/20/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $14.42 | General |
| Category: Psychology/Psychiatric | ||||||
| 02/14/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $28.53 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 01/17/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $25.42 | General |
| Category: Neuropsychiatry | ||||||
| 12/20/2023 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $23.38 | General |
| Category: CNS | ||||||
| 12/11/2023 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $16.94 | General |
| Category: PSYCHIATRY | ||||||
| 11/28/2023 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $25.64 | General |
| Category: PSYCHIATRY | ||||||
| 11/14/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug), ABILIFY MAINTENA | Food and Beverage | In-kind items and services | $17.81 | General |
| Category: PSYCHIATRY | ||||||
| 11/07/2023 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $125.69 | General |
| Category: PSYCHIATRY | ||||||
| 10/19/2023 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | Cash or cash equivalent | $97.96 | General |
| Category: Psychology/Psychiatric | ||||||
| 09/26/2023 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $29.42 | General |
| Category: PSYCHIATRY | ||||||
| 08/01/2023 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $18.74 | General |
| Category: NEUROSCIENCE | ||||||
| 07/25/2023 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $17.61 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 07/25/2023 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $1.87 | General |
| Category: CNS Stimulant for ADHD | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 300 | 1,007 | $148,743 | $71,229 |
| 2022 | 3 | 321 | 919 | $111,118 | $64,148 |
| 2021 | 4 | 323 | 803 | $102,215 | $65,384 |
| 2020 | 5 | 443 | 1,054 | $90,551 | $56,924 |
Total Patients
1,387
Total Services
3,783
Medicare Billing
$257,685
Procedure Codes
16
All Medicare Procedures & Services
16 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 158 | 585 | $109,335 | $49,788 | 45.5% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2023 | 118 | 376 | $33,474 | $18,239 | 54.5% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 11 | 28 | $3,730 | $2,084 | 55.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 13 | 18 | $2,204 | $1,117 | 50.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 173 | 551 | $79,896 | $46,475 | 58.2% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2022 | 107 | 299 | $23,982 | $14,320 | 59.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 41 | 69 | $7,240 | $3,353 | 46.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 166 | 540 | $77,160 | $50,726 | 65.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 90 | 146 | $14,790 | $8,274 | 55.9% |
| 90833 | Psychotherapy performed with evaluation and management visit, 30 minutes | Office | 2021 | 50 | 99 | $7,745 | $5,194 | 67.1% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 17 | 18 | $2,520 | $1,191 | 47.2% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 209 | 653 | $54,946 | $33,594 | 61.1% |
| 90833 | Psychotherapy, 30 minutes | Office | 2020 | 121 | 257 | $19,858 | $13,016 | 65.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 55 | 78 | $9,853 | $6,226 | 63.2% |
| 90836 | Psychotherapy, 45 minutes | Office | 2020 | 43 | 51 | $5,159 | $3,592 | 69.6% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 15 | 15 | $735.00 | $494.60 | 67.3% |
About Dr. George Dowell, M.D
Dr. George Dowell, M.D is a Psychiatry healthcare provider based in Saint Louis, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/30/2006. The National Provider Identifier (NPI) number assigned to this provider is 1750491130.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. George Dowell, M.D has received a total of $6,158 in payments from pharmaceutical and medical device companies, with $407.93 received in 2024. These payments were reported across 397 transactions from 35 companies. The most common payment nature is "Food and Beverage" ($6,150).
As a Medicare-enrolled provider, Dowell has provided services to 1,387 Medicare beneficiaries, totaling 3,783 services with total Medicare billing of $257,685. Data is available for 4 years (2020–2023), covering 16 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Location Saint Louis, MO
- Active Since 08/30/2006
- Last Updated 02/15/2024
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1750491130
Products in Payments
- REXULTI (Drug) $1,205
- LATUDA (Drug) $1,136
- VRAYLAR (Drug) $494.91
- CAPLYTA (Drug) $331.83
- VYVANSE (Drug) $275.80
- Adzenys XR-ODT (Drug) $267.97
- Trintellix (Drug) $253.48
- INGREZZA (Drug) $212.69
- ABILIFY MAINTENA (Drug) $151.65
- NUEDEXTA (Drug) $148.90
- AUSTEDO (Drug) $127.72
- Azstarys (Drug) $126.29
- Auvelity (Drug) $112.38
- INVEGA SUSTENNA (Drug) $107.44
- MYDAYIS (Drug) $100.98
- Fanapt (Drug) $98.11
- TRINTELLIX (Drug) $86.68
- INVEGA TRINZA (Drug) $75.07
- VIVITROL (Drug) $67.97
- ADHANSIA XR (Drug) $64.87
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Saint Louis
Dr. Mohd Malik, M.d, M.D
Psychiatry — Payments: $1.8M
Psychiatry $1.8M
Adam Sky, Md, MD
Psychiatry — Payments: $1.4M
Psychiatry $1.4M
Dr. Junaid Syed, M.d, M.D
Psychiatry — Payments: $1.1M
Psychiatry $1.1M
Dr. Michael Stotler, Md, MD
Psychiatry — Payments: $299,451
Psychiatry $299,451
Dr. Naji Chaaya Salloum, M.d, M.D
Psychiatry — Payments: $236,374
Psychiatry $236,374
Dr. Devnandini Rastogi, Md, MD
Psychiatry — Payments: $230,240
Psychiatry $230,240